BraveHeart Wireless announces FDA clearance of the BraveHeart life sensor cardiac monitoring system

BraveHeart Wireless Inc., a leading innovator in clinical-quality biometric wearables, announced that the company received clearance from the FDA for the BraveHeart Life Sensor Cardiac Monitoring system.

The Life Sensor Cardiac Monitoring system is intended for use by health care professionals within a health care setting. The system captures heart rate and EKG data using a Life Sensor electrode affixed to a patient�s skin and continuously transmits the data from the electrode to an application on an iOS device, where the data can be reviewed by health care professionals.

The Life Sensor Cardiac Monitoring system is a milestone product; it is the first product of its kind built on the BraveHeart Wireless Internet of Things (IoT) �open� platform. BraveHeart Wireless continues to develop additional health-related products on this platform as it works closely with key partners to configure its platform for targeted use models.

The Life Sensor Cardiac Monitoring system is comprised of several components, including a single-use, self-adhesive patch that can be attached to a patient�s skin directly above the heart. This patch is equipped with a sensor that can capture a patient�s heart rate and EKG data and wirelessly transmit this data via BLE (Bluetooth Low Energy) in real-time to an application on an iOS device, where the data can be reviewed by health care professionals.